Novel insight into FCSK‐congenital disorder of glycosylation through a CRISPR‐generated cell model

Background FCSK‐congenital disorder of glycosylation (FCSK‐CDG) is a recently discovered rare autosomal recessive genetic disorder with defective fucosylation due to mutations in the fucokinase encoding gene, FCSK. Despite the essential role of fucokinase in the fucose salvage pathway and severe mul...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular genetics & genomic medicine Jg. 12; H. 5; S. e2445 - n/a
Hauptverfasser: Fazelzadeh Haghighi, Maryam, Jafari Khamirani, Hossein, Fallahi, Jafar, Monfared, Ali Arabi, Ashrafi Dehkordi, Korosh, Tabei, Seyed Mohammad Bagher
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States John Wiley & Sons, Inc 01.05.2024
John Wiley and Sons Inc
Wiley
Schlagworte:
Age
Cell culture
Cell lines
Cell surface
Congenital anomalies
Congenital diseases
congenital disorder of glycosylation
Congenital Disorders of Glycosylation - genetics
Congenital Disorders of Glycosylation - metabolism
Congenital Disorders of Glycosylation - pathology
Convulsions & seizures
CRISPR
CRISPR-Cas Systems
CRISPR/Cas9
Design
Disease
Enzymes
Epilepsy
FCSK
Flow cytometry
Fucokinase
Fucose - metabolism
Gene expression
Genetic disorders
Glycoproteins
Glycosylation
Hereditary diseases
Humans
Intellectual disabilities
Molecular modelling
Notch3 protein
Original
Patients
Phosphotransferases (Alcohol Group Acceptor)
Polysaccharides
Receptors, Notch - genetics
Receptors, Notch - metabolism
congenital disorder of glycosylation
CRISPR/Cas9
FCSK
fucokinase
ISSN:2324-9269, 2324-9269
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background FCSK‐congenital disorder of glycosylation (FCSK‐CDG) is a recently discovered rare autosomal recessive genetic disorder with defective fucosylation due to mutations in the fucokinase encoding gene, FCSK. Despite the essential role of fucokinase in the fucose salvage pathway and severe multisystem manifestations of FCSK‐CDG patients, it is not elucidated which cells or which types of fucosylation are affected by its deficiency. Methods In this study, CRISPR/Cas9 was employed to construct an FCSK‐CDG cell model and explore the molecular mechanisms of the disease by lectin flow cytometry and real‐time PCR analyses. Results Comparison of cellular fucosylation by lectin flow cytometry in the created CRISPR/Cas9 FCSK knockout and the same unedited cell lines showed no significant change in the amount of cell surface fucosylated glycans, which is consistent with the only documented previous study on different cell types. It suggests a probable effect of this disease on secretory glycoproteins. Investigating O‐fucosylation by analysis of the NOTCH3 gene expression as a potential target revealed a significant decrease in the FCSK knockout cells compared with the same unedited ones, proving the effect of fucokinase deficiency on EGF‐like repeats O‐fucosylation. Conclusion This study expands insight into the FCSK‐CDG molecular mechanism; to the best of our knowledge, it is the first research conducted to reveal a gene whose expression level alters due to this disease. The current study exploring FCSK‐CDG through a CRISPR‐generated cell model demonstrated the effect of this disease on EGF‐like repeats O‐fucosylation by revealing NOTCH3 as the first identified gene whose expression level alters due to FCSK‐CDG. In addition, it suggested a probable effect of this disease on secretory glycoproteins.
Bibliographie:Seyed Mohammad Bagher Tabei and Korosh Ashrafi Dehkordi should be considered Joint senior author.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:2324-9269
2324-9269
DOI:10.1002/mgg3.2445